Internet portal of public authorities of the Kemerovo regionwww.kemobl.ru
Council of People's Deputies of the Kemerovo Regionwww.sndko.ru
Information portal "Kemerovo region"www.kemoblast.ru
Since the 70s of the last century, in the Kemerovo Cardiocenter under the leadership of Academician of the Russian Academy of Medical Sciences Leonid Semenovich Barbarash, the development of biological substitutes for cardiovascular surgery has been actively conducted.
On this scientific base, a small innovative enterprise "NeoKor" was created, which today annually produces more than 3.5 thousand bioprostheses, which provides 50% of all operations performed in Russia. At the same time, the cost of prostheses of domestic production is 3 times lower than imported analogues.
Currently, with the active participation of a team of motivated young scientists and researchers, a project is being developed to create serial production of elements of the cardiovascular system - tissue engineering methods based on our own unique developments.
Another promising area of activity of NeoKor CJSC is the development of a composite tissue structure based on nanotechnology intended for the treatment of burnt human tissues.
Scientific developments of the company were awarded the following prizes:
St. Jude Medical named after W.S. Lillechai;
Government of the Russian Federation on the basis of science and technology in 2000;
named after academician A.N. Bakuleva;
"Calling" to the best doctors of Russia for creating a new treatment method.
In 2003, the quality management system of the company "Development and Production of Prostheses for Cardiovascular Surgery" was certified for compliance with ISO 9001: 2008. The company became the first Russian manufacturer of medical devices to undergo such certification.
In 2009, on the basis of the research experimental laboratory, the Research Institute for Complex Problems of Cardiovascular Diseases of the SB RAS was created.
At present, close cooperation with the Research Institute of "Comprehensive Problems of Cardiovascular Diseases" SB RAS provides the company with the opportunity to develop innovative medical products and improve existing bioprosthesis.
NeoKor CJSC was granted the resident status of the Kuzbass Technopark in December 2008, in December 2010 the project was presented to the Council on Investment and Innovation Activities under the Governor of the Kemerovo Region in the new edition "Expansion and modernization of the production of biological prostheses for cardiovascular surgery with the launch of products international markets. " For 2012 and the 1st half of 2013, the organization received tax benefits on property tax and corporate income tax in the amount of more than 1 million rubles.
The project of NeoKor CJSC was approved on February 08, 2011 at a meeting of the Medical Technology and Pharmaceuticals Working Group of the Ministry of Industry and Trade of the Russian Federation (protocol No. ВХ-13/1261) with the wording "The Working Group members should take into account the need for comprehensive support and production of artificial limbs for the cardiac -vascular surgery "and is included in the register of projects in the direction of" Medical equipment and pharmaceuticals "of the Presidential Commission for the Modernization and Technological Development of the Russian Economy.
In 2018, the company received a certificate of a quality management system for compliance with ISO 13485: 2016 "Medical devices. Quality management systems. Requirements for regulatory purposes."
Consumers of products are cardiology clinics in Russia (Center for Intensive Cardiology and Cardiovascular Surgery based on the Krasnoyarsk Regional Clinical Hospital, Novosibirsk Regional Cardiology Dispensary, Rostov Regional Cardiology Dispensary, Center for Cardiac Surgery in Yekaterinburg, Institute of Cardiac Surgery named after V.I. Burakovsky).